No Data
Reported Earlier, Zai Lab Gains FDA Orphan Drug Designation For ZL-1310 In Small Cell Lung Cancer
Express News | Zai Lab Receives Orphan Drug Designation From the U.S. FDA for Zl-1310 (Dll3 ADC) for the Treatment of Small Cell Lung Cancer (Sclc)
Market Sentiment Around Loss-Making Zai Lab Limited (NASDAQ:ZLAB)
Trump Told Advisers He Wants to Visit China as President
GF SEC: VERTEX JPM meeting update, focusing on the progress in the fields of domestic enterprise pain and kidney disease.
The success of Suzetrigine offers hope for the development of the Nav1.8 target, and based on its inherent mechanism advantages, it is expected to bring a new, safer, and more effective therapy for pain patients.
Sector Update: Health Care Stocks Decline Late Afternoon
